Articles by James Calloway
IonQ Q1 Earnings: Quantum Growth Meets Market Reality
IonQ reports Q1 earnings with revenue of $49.8M and a loss of 46 cents per share. Shares rose 2.6% to $49.26 as investors weigh growth against risks.
Kraft Heinz Q1 Sales Beat Fuels CEO's Turnaround Strategy
Kraft Heinz beat Q1 sales estimates, sending shares up 3.6%. CEO Steve Cahillane's $600M turnaround plan gets an early boost as brand investment ramps up.
CVS Health Upgrades 2026 Profit View as Aetna Cost Controls Boost Q1 Results
CVS Health raised its 2026 profit outlook after a strong Q1, with revenue topping $100 billion and Aetna's medical benefit ratio improving to 84.6%. Shares surged 9%.
Disney Beats Q2 Estimates as Streaming Profits Surge, Parks Hold Steady
Disney topped Q2 expectations with streaming profits surging 88% and parks revenue steady. New CEO Josh D'Amaro targets 12-16% EPS growth for fiscal 2026.
CoreWeave Faces $66.8B Backlog Test as Q1 Earnings Loom
CoreWeave reports Q1 earnings after the close May 7, with a $66.8B backlog and major deals with Meta, Anthropic, and Jane Street. Investors eye execution risks.
Uber's Strong Bookings Forecast Puts Pressure on Lyft Ahead of Earnings
Uber forecast Q2 gross bookings of $56.25-$57.75B, above estimates, after a Q1 revenue miss. Shares rose ~8% premarket. Lyft reports after Thursday's close.
Verizon Shifts Strategy: Ends Blanket Free Phone Offers, Targets Retention
Verizon CEO Dan Schulman ends blanket free phone and line offers, shifting to targeted retention. The carrier added 55,000 postpaid subscribers in Q1, its first positive Q1 since 2013.
Novo Nordisk Shares Surge on Strong Wegovy Pill Sales, Upgraded 2026 Outlook
Novo Nordisk raised its 2026 guidance after Wegovy pill prescriptions topped 2 million, sending shares up 9.2%. The company now expects a smaller decline in sales and profit this year.
Palantir Stock Dips Despite Record Q1 as U.S. Commercial Revenue Misses Estimates
Palantir shares dropped 6.9% on Tuesday after U.S. commercial revenue fell short of analyst expectations, overshadowing record Q1 results and an increased 2026 outlook.
Tesla Recalls 218,868 Vehicles in US; European FSD Approval Stalls
Tesla recalls 218,868 US vehicles over rearview camera delay. Stock slips 0.8% as European FSD approval faces regulatory hurdles.